Cargando…

A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin

RATIONALE: Posterior reversible encephalopathy syndrome (PRES) is a subacute syndrome causing characteristic neurologic and radiologic findings. PRES is predominantly caused by malignant hypertension though it has been associated with immunosuppressive treatments such as chemotherapy. PATIENT CONCER...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cherniawsky, Hannah, Merchant, Neesha, Sawyer, Micheal, Ho, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569414/ https://www.ncbi.nlm.nih.gov/pubmed/28225482 http://dx.doi.org/10.1097/MD.0000000000005850

Ejemplares similares

Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature
por: Kabre, Rohit Santosh, et al.
Publicado: (2016)

Gemcitabine Monotherapy Associated with Posterior Reversible Encephalopathy Syndrome
por: Marrone, Luiz Carlos Porcello, et al.
Publicado: (2011)

Percutaneous intratumoral injection of gemcitabine plus cisplatin mixed with fibrin glue for advanced pancreatic carcinoma: Case Report
por: Yang, Biao, et al.
Publicado: (2017)

Reversible posterior leukoencephalopathy syndrome following apatinib for gastric cancer in an adult: A case report and a review of the literature
por: Lv, Yajuan, et al.
Publicado: (2019)

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma
por: Luo, Zhiguo, et al.
Publicado: (2015)

Gemcitabine, cisplatin, and dexamethasone and ifosfamide, carboplatin, and etoposide regimens have similar efficacy as salvage treatment for relapsed/refractory aggressive lymphoma: A retrospectively comparative study
por: Mi, Mi, et al.
Publicado: (2020)

Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Li, Doudou, et al.
Publicado: (2015)

GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
por: Wang, Jing-jing, et al.
Publicado: (2016)

A case report of Wernicke Korsakoff syndrome in a patient with cholangiocellular carcinoma: An underestimated cause of encephalopathy in cancer patients
por: Koca, Oguzhan, et al.
Publicado: (2022)

Apatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient: A case report
por: Liang, Lijun, et al.
Publicado: (2017)

Posterior reversible encephalopathy syndrome
por: Fischer, Marlene, et al.
Publicado: (2017)

Posterior Reversible Encephalopathy Syndrome
por: Gewirtz, Alexandra N., et al.
Publicado: (2021)

Reversible cerebral vasoconstriction with thunderclap headache: A case report
por: Ji, Jae Young, et al.
Publicado: (2019)

Evaluation of gemcitabine efficacy after the FOLFIRINOX regimen in patients with advanced pancreatic adenocarcinoma
por: Gilabert, Marine, et al.
Publicado: (2017)

Malignant Posterior Reversible Encephalopathy Syndrome: A Case of Posterior Irreversible Encephalopathy Syndrome
por: Martins, William Alves, et al.
Publicado: (2016)

A Case of Posterior Reversible Encephalopathy Syndrome Induced by Cisplatin/Pemetrexed Chemotherapy for Lung Cancer
por: Ishihara, Masashi, et al.
Publicado: (2017)

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy
por: Quirino, Michela, et al.
Publicado: (2017)

Posterior reversible encephalopathy syndrome postpartum
por: Nielsen, Lise Hald, et al.
Publicado: (2015)

Posterior Reversible Encephalopathy Syndrome in ALL
por: Millichap, J. Gordon
Publicado: (2015)

Posterior reversible encephalopathy syndrome(PRES)
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2017)

Brainstem Posterior Reversible Encephalopathy Syndrome
por: Hama, Ryosuke, et al.
Publicado: (2019)

Posterior Reversible Encephalopathy Syndrome (PRES)
por: Ciozda, William, et al.
Publicado: (2020)

D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report
por: Matsumoto, Yu, et al.
Publicado: (2021)

Can Thymidine Phosphorylase Be a Predictive Marker for Gemcitabine and Doxifluridine Combination Chemotherapy in Cholangiocarcinoma?: Case Series
por: Kang, Myoung Hee, et al.
Publicado: (2014)

Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
por: Nakano, Shintaro, et al.
Publicado: (2020)

T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report
por: Shao, Yajuan, et al.
Publicado: (2018)

Cisplatin-induced sudden cardiac death with hemodynamic collapse: a severe adverse drug reaction: Case report
por: Abramavicius, Silvijus, et al.
Publicado: (2017)

A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer
por: Fukahori, Masaru, et al.
Publicado: (2021)

Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients
por: Wang, Bing, et al.
Publicado: (2016)

Pemetrexed/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases: A case report and literature review
por: He, Guangzhao, et al.
Publicado: (2016)

dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Study
por: Xiong, Junjie, et al.
Publicado: (2016)

The efficacy and safety of gemcitabine-based induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A meta-analysis
por: Fei, Qian, et al.
Publicado: (2021)

Efficacy and safety of gemcitabine-capecitabine combination therapy for pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials
por: Ouyang, Guoqing, et al.
Publicado: (2021)

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Sen, Fatma, et al.
Publicado: (2016)

Pneumonitis in cancer patients receiving anti-PD-1 and radiotherapies: Three case reports
por: Lu, Chieh-Sheng, et al.
Publicado: (2017)

Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature
por: Song, Jin-cheng, et al.
Publicado: (2017)

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017)

Posterior reversible encephalopathy syndrome at term pregnancy
por: Achar, Shreepathi Krishna, et al.
Publicado: (2011)

Posterior reversible encephalopathy syndrome in neuro-malaria
por: Lacout, Alexis, et al.
Publicado: (2010)

Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
por: Costa, Ricardo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6556mhfjabuvsm01r20mc85qqf